KR101798024B1 - 자외선 차단 기능을 갖는 투명 화장료 조성물 - Google Patents
자외선 차단 기능을 갖는 투명 화장료 조성물 Download PDFInfo
- Publication number
- KR101798024B1 KR101798024B1 KR1020170082677A KR20170082677A KR101798024B1 KR 101798024 B1 KR101798024 B1 KR 101798024B1 KR 1020170082677 A KR1020170082677 A KR 1020170082677A KR 20170082677 A KR20170082677 A KR 20170082677A KR 101798024 B1 KR101798024 B1 KR 101798024B1
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- weight
- comparative example
- organic
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 124
- 239000002537 cosmetic Substances 0.000 title claims abstract description 82
- 230000006870 function Effects 0.000 title description 13
- 230000006750 UV protection Effects 0.000 title description 2
- 229920001971 elastomer Polymers 0.000 claims abstract description 35
- 239000000806 elastomer Substances 0.000 claims abstract description 35
- 239000002981 blocking agent Substances 0.000 claims abstract description 26
- 230000002087 whitening effect Effects 0.000 claims abstract description 13
- 229940008099 dimethicone Drugs 0.000 claims description 26
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 26
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 26
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 26
- 229920006037 cross link polymer Polymers 0.000 claims description 21
- 230000000903 blocking effect Effects 0.000 claims description 17
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 15
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 14
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 claims description 14
- 229960004881 homosalate Drugs 0.000 claims description 14
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 13
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 13
- 229960005193 avobenzone Drugs 0.000 claims description 13
- 229960001679 octinoxate Drugs 0.000 claims description 13
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 9
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 8
- 239000000516 sunscreening agent Substances 0.000 claims description 8
- CZVOIAOPRGNENY-UHFFFAOYSA-N 2-butyloctyl 2-hydroxybenzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O CZVOIAOPRGNENY-UHFFFAOYSA-N 0.000 claims description 7
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 claims description 7
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000000475 sunscreen effect Effects 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 4
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 claims description 4
- UUGLJVMIFJNVFH-UHFFFAOYSA-N Hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1 UUGLJVMIFJNVFH-UHFFFAOYSA-N 0.000 claims description 4
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 claims description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 4
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 4
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 claims description 4
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 4
- 229940100498 polysilicone-15 Drugs 0.000 claims description 4
- 229920002282 polysilicones-15 Polymers 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- PBFGMXZRJIUGKU-UHFFFAOYSA-N 3-decanoyloxybutyl decanoate Chemical compound CCCCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCCCC PBFGMXZRJIUGKU-UHFFFAOYSA-N 0.000 claims description 3
- LFESLSYSZQYEIZ-UHFFFAOYSA-N 3-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCC LFESLSYSZQYEIZ-UHFFFAOYSA-N 0.000 claims description 3
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 229940114374 butylene glycol dicaprylate Drugs 0.000 claims description 3
- 230000003750 conditioning effect Effects 0.000 claims description 3
- 229940100539 dibutyl adipate Drugs 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 claims description 2
- XXENILDVNSEZLJ-UHFFFAOYSA-N 3-(diethylamino)-2-hydroxybenzoic acid Chemical compound CCN(CC)C1=CC=CC(C(O)=O)=C1O XXENILDVNSEZLJ-UHFFFAOYSA-N 0.000 claims 1
- OOHTWBUKWQKKEE-UHFFFAOYSA-N [6-(diethylamino)-6-hydroxy-7-oxo-7-phenylheptyl] benzoate Chemical compound C=1C=CC=CC=1C(=O)C(O)(N(CC)CC)CCCCCOC(=O)C1=CC=CC=C1 OOHTWBUKWQKKEE-UHFFFAOYSA-N 0.000 claims 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 claims 1
- 229920005591 polysilicon Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 230000000052 comparative effect Effects 0.000 description 115
- 238000012216 screening Methods 0.000 description 22
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 18
- 238000009472 formulation Methods 0.000 description 18
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 9
- 229960000601 octocrylene Drugs 0.000 description 9
- 239000004408 titanium dioxide Substances 0.000 description 9
- 239000008187 granular material Substances 0.000 description 7
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 6
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 5
- 229940100524 ethylhexylglycerin Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 5
- LUZBWFDMAMZIEI-UHFFFAOYSA-N 3-[6-(diethylamino)hexoxy]-2-(7-oxo-7-phenylheptyl)benzoic acid Chemical compound CCN(CC)CCCCCCOC1=CC=CC(=C1CCCCCCC(=O)C2=CC=CC=C2)C(=O)O LUZBWFDMAMZIEI-UHFFFAOYSA-N 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- -1 Hydroxybenzoyl hexyl Chemical group 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000013538 functional additive Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- PYFVRMNFLPOIHE-UHFFFAOYSA-N 1-phenylethanone;sodium Chemical compound [Na].CC(=O)C1=CC=CC=C1 PYFVRMNFLPOIHE-UHFFFAOYSA-N 0.000 description 1
- KZYKVEGBVFDESS-UHFFFAOYSA-N 2-hexoxy-3-hexylbenzoic acid Chemical compound CCCCCCC1=C(C(=CC=C1)C(=O)O)OCCCCCC KZYKVEGBVFDESS-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 1
- HRGXTYVIVADAHN-UHFFFAOYSA-N 5-methoxy-4-phenyltriazine;phenol Chemical compound OC1=CC=CC=C1.COC1=CN=NN=C1C1=CC=CC=C1 HRGXTYVIVADAHN-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- KKVZAVRSVHUSPL-GQCTYLIASA-N Cassiastearoptene Chemical compound COC1=CC=CC=C1\C=C\C=O KKVZAVRSVHUSPL-GQCTYLIASA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241001071864 Lethrinus laticaudis Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- KKVZAVRSVHUSPL-UHFFFAOYSA-N o-methoxycinnamic aldehyde Natural products COC1=CC=CC=C1C=CC=O KKVZAVRSVHUSPL-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/415—Aminophenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
도 2는 실시예 2를 나타낸 도면이다.
도 3은 실시예 3(왼쪽) 및 4(오른쪽)를 나타낸 도면이다.
도 4는 비교예 1을 나타낸 도면이다.
도 5는 비교예 2를 나타낸 도면이다.
도 6은 비교예 3을 나타낸 도면이다.
도 7은 비교예 4를 나타낸 도면이다.
도 8은 비교예 5를 나타낸 도면이다.
도 9는 비교예 6을 나타낸 도면이다.
도 10은 비교예 7을 나타낸 도면이다.
도 11은 비교예 9를 나타낸 도면이다.
도 12는 비교예 10을 나타낸 도면이다.
도 13은 비교예 12를 나타낸 도면이다.
도 14는 비교예 12를 나타낸 도면이다.
도 15는 비교예 13을 나타낸 도면이다.
도 16은 비교예 14를 나타낸 도면이다.
도 17은 비교예 15(왼쪽), 16, 17, 18(오른쪽)을 나타낸 도면이다.
| 실시예(중량%) | 1 | 2 | 3 | 4 | 5 | 6 |
| 엘라스토머(A) | - | 55.0 | 25.0 | 30.0 | - | - |
| 엘라스토머(B) | 55.0 | - | 30.0 | 25.0 | 55.0 | 55.0 |
| 에칠헥실메톡시신나메이트 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 7.0 |
| 에칠헥실살리실레이트 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 |
| 호모살레이트 | 7.0 | 7.0 | 7.0 | 7.0 | 6.5 | 7.0 |
| 폴리실리콘-15 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 |
| 이소아밀p-메톡시신나메이트 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 2.0 |
| 에칠헥실트리아존 | 1.5 | 1.5 | 1.5 | 1.5 | 1.0 | 1.5 |
| 부틸메톡시디벤조일메탄 | 1.0 | 1.0 | 1.0 | 1.0 | 3.0 | - |
| 비스-에칠헥실옥시페놀메톡시페닐트리아진 | 2.5 | 2.5 | 2.5 | 2.5 | 1.5 | 2.0 |
| 디에칠아미노하이드록시벤조일헥실벤조에이트 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.5 |
| 부틸옥틸살리실레이트 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 |
| 비사보롤 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| 에칠헥실글리세린 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| 토코페릴아세테이트 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| 총합 | 100 | |||||
| 비교예 ( 중량% ) | 1 | 2 | 3 | 4 |
| 엘라스토머(B) | 55.0 | 55.0 | 55.0 | 55.0 |
| 에칠헥실메톡시신나메이트 | 5.0 | 5.0 | 5.0 | 5.0 |
| 에칠헥실살리실레이트 | 5.0 | 5.0 | 5.0 | 5.0 |
| 호모살레이트 | 7.0 | 7.0 | 7.0 | 7.0 |
| 폴리실리콘-15 | 4.0 | 4.0 | 4.0 | 4.0 |
| 이소아밀p-메톡시신나메이트 | 3.0 | 3.0 | 3.0 | 3.0 |
| 에칠헥실트리아존 | 1.5 | 1.5 | 1.5 | 1.5 |
| 부틸메톡시디벤조일메탄 | 1.0 | 1.0 | 1.0 | 1.0 |
| 비스-에칠헥실옥시페놀메톡시페닐트리아진 | 2.5 | 2.5 | 2.5 | 2.5 |
| 디에칠아미노하이드록시벤조일헥실벤조에이트 | 1.0 | 1.0 | 1.0 | 1.0 |
| 옥토크릴렌 | 4.0 | 1.0 | - | 1.0 |
| 티타늄 디옥사이드 | - | - | 2.0 | 1.0 |
| 부틸옥틸살리실레이트 | 10.0 | 12.0 | 11.0 | 11.0 |
| 비사보롤 | 0.5 | 0.5 | 0.5 | 0.5 |
| 에칠헥실글리세린 | - | 1.0 | 1.0 | 1.0 |
| 토코페릴아세테이트 | 0.5 | 0.5 | 0.5 | 0.5 |
| 총합 | 100 | |||
| 비교예 ( 중량% ) | 5 | 6 | 7 | 8 |
| 엘라스토머(B) | 55.0 | 55.0 | 55.0 | 55.0 |
| 에칠헥실메톡시신나메이트 | 6.0 | 6.5 | 7.0 | 7.0 |
| 에칠헥실살리실레이트 | 5.0 | 5.0 | 5.0 | 5.0 |
| 호모살레이트 | 6.0 | 7.0 | 7.0 | 7.0 |
| 폴리실리콘-15 | - | 2.0 | 2.0 | 2.5 |
| 이소아밀p-메톡시신나메이트 | 2.0 | 2.0 | 5.0 | 5.0 |
| 에칠헥실트리아존 | 2.0 | 2.0 | - | 1.0 |
| 부틸메톡시디벤조일메탄 | 3.0 | 2.5 | 1.5 | - |
| 비스-에칠헥실옥시페놀메톡시페닐트리아진 | 3.0 | - | 1.5 | 1.5 |
| 디에칠아미노하이드록시벤조일헥실벤조에이트 | 3.0 | 3.0 | 1.0 | 1.0 |
| 부틸옥틸살리실레이트 | 12.0 | 12.0 | 12.0 | 12.0 |
| 비사보롤 | 1.0 | 1.0 | 1.0 | 1.0 |
| 에칠헥실글리세린 | 1.0 | 1.0 | 1.0 | 1.0 |
| 토코페릴아세테이트 | 1.0 | 1.0 | 1.0 | 1.0 |
| 총합 | 100 | |||
| 비교예 ( 중량% ) | 9 | 10 | 11 | 12 | 13 | 14 |
| 엘라스토머(B) | 30.0 | 75.0 | 60.0 | 40.0 | 55.0 | 40.0 |
| 에칠헥실메톡시신나메이트 | 5.0 | 3.0 | 0.5 | 4.0 | 5.0 | 3.0 |
| 에칠헥실살리실레이트 | 5.0 | 3.0 | - | 5.5 | 5.0 | 5.0 |
| 호모살레이트 | 7.0 | 1.0 | 0.1 | 7.0 | 7.0 | 5.0 |
| 폴리실리콘-15 | 4.0 | 1.0 | 0.5 | 4.0 | 4.0 | 4.0 |
| 이소아밀p-메톡시신나메이트 | 3.0 | 1.5 | 0.3 | 1.5 | 3.0 | 2.0 |
| 에칠헥실트리아존 | 1.5 | 0.5 | 2.0 | 11.0 | 1.5 | 1.5 |
| 부틸메톡시디벤조일메탄 | 1.0 | 1.0 | - | 5.0 | 1.0 | 1.0 |
| 비스-에칠헥실옥시페놀메톡시페닐트리아진 | 2.5 | 0.5 | 0.1 | 11.0 | 2.5 | 2.5 |
| 디에칠아미노하이드록시벤조일헥실벤조에이트 | 1.0 | 1.0 | - | 1.0 | 1.0 | 1.0 |
| 부틸옥틸살리실레이트 | 25.0 | 12.5 | 25.0 | 10.0 | - | 35.0 |
| 비사보롤 | 5.0 | - | 4.0 | - | 5.0 | - |
| 에칠헥실글리세린 | 5.0 | - | 5.0 | - | 5.0 | - |
| 토코페릴아세테이트 | 5.0 | - | 2.5 | - | 5.0 | - |
| 총합 | 100 | |||||
| 엘라스토머 종류 | |
| 비교예15 | 세테아릴디메치콘크로스폴리머 (Cetearyl Dimethicone Crosspolymer) |
| 비교예16 | 디메치콘/비닐디메치콘크로스폴리머 (Dimethicone/Vinyl Dimethicone Crosspolymer) |
| 비교예17 | 디메치콘/피이지-10/15크로스폴리머 (Dimethicone/PEG-10/15 Crosspolymer) |
| 비교예18 | 피이지/피피지-20/15디메치콘 (PEG/PPG-20/15 Dimethicone) |
| 투명도 | 투명도 | ||
| 실시예1 | 9.8 | 비교예7 | 2.5 |
| 실시예2 | 9.0 | 비교예8 | 2.2 |
| 실시예3 | 9.3 | 비교예9 | 3.5 |
| 실시예4 | 9.2 | 비교예10 | - |
| 실시예5 | 9.4 | 비교예11 | 6.5 |
| 실시예6 | 9.4 | 비교예12 | - |
| 비교예1 | 0 | 비교예13 | - |
| 비교예2 | 0 | 비교예14 | 3.0 |
| 비교예3 | 0 | 비교예15 | 0.1 |
| 비교예4 | 0 | 비교예16 | 0.1 |
| 비교예5 | - | 비교예17 | 0.3 |
| 비교예6 | - | 비교예18 | 0.5 |
| UV 차단 지수 |
Critical wavelength | UV 차단 지수 |
Critical wavelength | ||
| 실시예1 | 72 | 377 | 비교예7 | 21 | 346 |
| 실시예2 | 66 | 376 | 비교예8 | 16 | 345 |
| 실시예3 | 68 | 377 | 비교예9 | 10 | 333 |
| 실시예4 | 68 | 376 | 비교예10 | 25 | 343 |
| 실시예5 | 70 | 376 | 비교예11 | 12 | 310 |
| 실시예6 | 70 | 376 | 비교예12 | 30 | 342 |
| 비교예1 | 75 | 377 | 비교예13 | 37 | 345 |
| 비교예2 | 68 | 376 | 비교예14 | 26 | 340 |
| 비교예3 | - | - | 비교예15 | 43 | 361 |
| 비교예4 | - | - | 비교예16 | 46 | 360 |
| 비교예5 | 30 | 350 | 비교예17 | 50 | 365 |
| 비교예6 | 35 | 353 | 비교예18 | 43 | 360 |
| 커버력 | 부착력 | 백탁현상 | |
| 실시예1 | 4.50 | 4.18 | Х |
| 실시예2 | 4.18 | 4.01 | Х |
| 실시예3 | 4.33 | 4.03 | Х |
| 실시예4 | 4.31 | 4.02 | Х |
| 실시예5 | 4.47 | 4.15 | Х |
| 실시예6 | 4.45 | 4.14 | Х |
| 비교예1 | 1.85 | 1.14 | О |
| 비교예2 | 2.44 | 2.56 | О |
| 비교예3 | - | - | - |
| 비교예4 | - | - | - |
| 비교예5 | - | - | - |
| 비교예6 | - | - | - |
| 비교예7 | 1.20 | 1.11 | Х |
| 비교예8 | 0.55 | 0.22 | Х |
| 비교예9 | - | - | - |
| 비교예10 | - | - | - |
| 비교예11 | 3.41 | 3.20 | О |
| 비교예12 | - | - | - |
| 비교예13 | - | - | - |
| 비교예14 | - | - | - |
| 비교예15 | 2.15 | 3.01 | О |
| 비교예16 | 2.46 | 2.99 | О |
| 비교예17 | 2.19 | 3.42 | О |
| 비교예18 | 2.11 | 3.05 | О |
Claims (7)
- 엘라스토머, 오일, 유기 자외선 차단제 조성물을 포함하고,
상기 유기 자외선 차단제 조성물은
에칠헥실메톡시신나메이트(Ethylhexyl Methoxycinnamate), 에칠헥실살리실레이트(Ethylhexyl Salicylate), 호모살레이트(Homosalate), 폴리실리콘-15(Polysilicone-15) 및 이소아밀p-메톡시신나메이트(Isoamyl p-Methoxycinnamate)로 이루어진 군에서 선택되는 하나 이상을 포함하는 액체 상태의 유기 자외선 차단제; 및
에칠헥실트리아존(Ethylhexyl Triazone), 부틸메톡시디벤조일메탄(Butyl Methoxydibenzoylmethane), 비스-에칠헥실옥시페놀메톡시페닐트리아진(Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine) 및 디에칠아미노하이드록시벤조일헥실벤조에이트(Diethylamino Hydroxybenzoyl Hexyl Benzoate)로 이루어진 군에서 선택된 하나 이상을 포함하는 고체 상태의 유기 자외선 차단제;를 3.5 ~ 5 : 1의 중량비로 포함하는, 자외선 차단 기능을 갖는 투명 화장료 조성물.
- 제 1 항에 있어서,
상기 투명 화장료 조성물은
상기 투명 화장료 조성물 총 중량 기준으로 상기 엘라스토머 35 ~ 70 중량%, 상기 오일 1 ~ 30 중량% 및 상기 유기 자외선 차단제 조성물 5 ~ 40 중량%를 포함하는, 자외선 차단 기능을 갖는 투명 화장료 조성물.
- 제 1 항에 있어서,
상기 엘라스토머는
(A) 디메치콘/비스-이소부틸 피피지-20 크로스폴리머(Dimethicone/Bis-isobutyl PPG-20 crosspolymer) 및 (B)피이지-12 디메치콘/피피지-20 크로스폴리머(PEG-12 Dimethicone/PPG-20 crosspolymer)로 이루어진 군에서 선택된 하나 이상을 포함하는, 자외선 차단 기능을 갖는 투명 화장료 조성물.
- 삭제
- 제 1 항에 있어서,
상기 유기 자외선 차단제 조성물은
상기 투명 화장료 조성물 총 중량 기준으로 에칠헥실메톡시신나메이트 3 ~ 20 중량%, 에칠헥실살리실레이트 3 ~ 20 중량%, 호모살레이트 0.1 ~ 20 중량%, 폴리실리콘-15 0.1 ~ 20 중량%, 이소아밀p-메톡시신나메이트 0.1 ~ 20 중량%, 에칠헥실트리아존 0.1 ~ 10 중량%, 부틸메톡시디벤조일메탄 0.1 ~ 10 중량%, 비스-에칠헥실옥시페놀메톡시페닐트리아진 0.1 ~ 10 중량%, 디에칠아미노하이드록시벤조일헥실벤조에이트 0.1 ~ 10 중량%로 포함하는 것을 특징으로 하는, 자외선 차단 기능을 갖는 투명 화장료 조성물.
- 제 1 항에 있어서,
상기 오일은 부틸옥틸살리실레이트(Butyloctyl Salicylate), 디부틸아디페이트(Dibutyl Adipate), 부틸렌글라이콜디카프릴레이트/디카프레이트(Butylene Glycol Dicaprylate/Dicaprate), 카프릴릴메치콘(Caprylyl Methicone), 이소도데칸(Isododecane), 이소헥사데칸(Isohexadecane), C15-19 알케인(C15-19 alkane) 및 디카프릴릴카보네이트(Dicaprylyl Carbonate)로 이루어진 군에서 선택된 하나 이상을 포함하는, 자외선 차단 기능을 갖는 투명 화장료 조성물.
- 제 1 항에 있어서,
상기 투명 화장료 조성물은
방부제, 미백제, 항산화제, 피부컨티셔닝제 및 계면활성제로 이루어진 군에서 선택된 하나 이상의 첨가제를 더 포함하는, 자외선 차단 기능을 갖는 투명 화장료 조성물.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170082677A KR101798024B1 (ko) | 2017-06-29 | 2017-06-29 | 자외선 차단 기능을 갖는 투명 화장료 조성물 |
| US16/626,784 US20200113798A1 (en) | 2017-06-29 | 2018-05-18 | Transparent cosmetic composition having ultraviolet screening function |
| PCT/KR2018/005706 WO2019004596A1 (ko) | 2017-06-29 | 2018-05-18 | 자외선 차단 기능을 갖는 투명 화장료 조성물 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170082677A KR101798024B1 (ko) | 2017-06-29 | 2017-06-29 | 자외선 차단 기능을 갖는 투명 화장료 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR101798024B1 true KR101798024B1 (ko) | 2017-11-16 |
Family
ID=60806849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020170082677A Active KR101798024B1 (ko) | 2017-06-29 | 2017-06-29 | 자외선 차단 기능을 갖는 투명 화장료 조성물 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20200113798A1 (ko) |
| KR (1) | KR101798024B1 (ko) |
| WO (1) | WO2019004596A1 (ko) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019004596A1 (ko) * | 2017-06-29 | 2019-01-03 | 한국콜마주식회사 | 자외선 차단 기능을 갖는 투명 화장료 조성물 |
| KR102012161B1 (ko) * | 2019-04-03 | 2019-08-20 | 한국콜마주식회사 | 자외선 차단용 화장료 조성물 |
| WO2020088778A1 (en) * | 2018-11-02 | 2020-05-07 | Symrise Ag | A liquid and transparent blend of uv filters |
| KR20200126054A (ko) | 2019-04-29 | 2020-11-06 | 우용규 | 피부의 산화, 염증 및 세포사멸의 억제효능을 가지는 조성물 |
| KR102419912B1 (ko) * | 2022-01-19 | 2022-07-13 | 박혜랑 | 미스트 타입 자외선 차단 화장료 조성물 |
| KR20230147588A (ko) * | 2019-08-20 | 2023-10-23 | 주식회사 엘지생활건강 | 크로마틱 에멀젼 성상을 갖는 자외선 차단용 화장료 조성물 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230115322A (ko) * | 2020-12-09 | 2023-08-02 | 디에스엠 아이피 어셋츠 비.브이. | 다이에틸아미노 하이드록시벤조일 헥실 벤조에이트의증가된 가용화 |
| FR3162629A1 (fr) * | 2024-05-31 | 2025-12-05 | L'oreal | Mélange translucide et homogène de filtres UV organiques lipophiles solides |
| ES3048530B2 (es) * | 2024-06-06 | 2026-05-04 | Valquer Laboratorios Slu | Protector solar transparente |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060040151A (ko) * | 2004-11-04 | 2006-05-10 | 주식회사 엘지생활건강 | 자외선 차단 화장료 조성물 |
| US20070128137A1 (en) * | 2005-12-02 | 2007-06-07 | Naohisa Yoshimi | Water in oil emulsion compositions containing siloxane elastomers |
| US20110189113A1 (en) * | 2007-08-13 | 2011-08-04 | Tracey Ross | Water-Resistant, Rub-Resistant, Sprayable Homogeneous Sunscreen Composition |
| KR20120042397A (ko) * | 2010-10-25 | 2012-05-03 | (주)아모레퍼시픽 | 실리콘 엘라스토머를 다량 함유한 유중수형 자외선 차단용 화장료 조성물 |
| KR102249023B1 (ko) * | 2014-01-28 | 2021-05-07 | 코스맥스 주식회사 | 유기 자외선 차단제를 이용한 투명한 스프레이형 자외선 차단용 화장료 조성물 |
| KR101659844B1 (ko) * | 2014-10-16 | 2016-09-30 | 주식회사 코리아나화장품 | 무수 메이크업 화장료 조성물 |
| KR101798024B1 (ko) * | 2017-06-29 | 2017-11-16 | 한국콜마주식회사 | 자외선 차단 기능을 갖는 투명 화장료 조성물 |
-
2017
- 2017-06-29 KR KR1020170082677A patent/KR101798024B1/ko active Active
-
2018
- 2018-05-18 US US16/626,784 patent/US20200113798A1/en not_active Abandoned
- 2018-05-18 WO PCT/KR2018/005706 patent/WO2019004596A1/ko not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| I.V.Reeth외 1명, A Hydrophilic Silicone Elastomer for Broader Formulating Flexibility, Cosmetics and Toileties (2013.06.25) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019004596A1 (ko) * | 2017-06-29 | 2019-01-03 | 한국콜마주식회사 | 자외선 차단 기능을 갖는 투명 화장료 조성물 |
| WO2020088778A1 (en) * | 2018-11-02 | 2020-05-07 | Symrise Ag | A liquid and transparent blend of uv filters |
| US11723850B2 (en) | 2018-11-02 | 2023-08-15 | Symrise, AG | Liquid and transparent blend of UV filters |
| AU2018448228B2 (en) * | 2018-11-02 | 2025-04-17 | Symrise Ag | A liquid and transparent blend of UV filters |
| KR102012161B1 (ko) * | 2019-04-03 | 2019-08-20 | 한국콜마주식회사 | 자외선 차단용 화장료 조성물 |
| KR20200126054A (ko) | 2019-04-29 | 2020-11-06 | 우용규 | 피부의 산화, 염증 및 세포사멸의 억제효능을 가지는 조성물 |
| KR20230147588A (ko) * | 2019-08-20 | 2023-10-23 | 주식회사 엘지생활건강 | 크로마틱 에멀젼 성상을 갖는 자외선 차단용 화장료 조성물 |
| KR102714890B1 (ko) | 2019-08-20 | 2024-10-11 | 주식회사 엘지생활건강 | 크로마틱 에멀젼 성상을 갖는 자외선 차단용 화장료 조성물 |
| KR102419912B1 (ko) * | 2022-01-19 | 2022-07-13 | 박혜랑 | 미스트 타입 자외선 차단 화장료 조성물 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019004596A1 (ko) | 2019-01-03 |
| US20200113798A1 (en) | 2020-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200113798A1 (en) | Transparent cosmetic composition having ultraviolet screening function | |
| JP6867293B2 (ja) | 日焼け止め化粧料 | |
| KR102678386B1 (ko) | 폴리글리세릴 계열의 계면활성제를 함유하는 자외선 차단 화장료 조성물 | |
| KR102284873B1 (ko) | 자외선에 의해 자외선 차단 효율이 증가하는 자외선 차단용 화장료 조성물 | |
| EP3870309B1 (en) | Mineral sunscreen compositions with improved efficacy | |
| US20120231058A1 (en) | Cosmetic Composition Containing Inorganic Powder | |
| ES2797751T3 (es) | Composición basada en partículas compuestas esféricas multicapa y en un agente de protección de UV | |
| KR102498844B1 (ko) | 무기자외선차단제 고함유 자외선차단 화장료 조성물 | |
| JPWO2020032246A1 (ja) | 日やけ止め効果増強剤 | |
| KR20120042397A (ko) | 실리콘 엘라스토머를 다량 함유한 유중수형 자외선 차단용 화장료 조성물 | |
| US20140161848A1 (en) | Uv protective cosmetic composition | |
| WO2020032243A1 (ja) | 乳化化粧料 | |
| EP3834809A1 (en) | Oil-based cosmetic | |
| JP7347993B2 (ja) | 日焼け止め用組成物 | |
| KR20130056700A (ko) | 유중수 형태의 투명한 자외선 차단 조성물 | |
| ES2954123T3 (es) | Composición fotoprotectora a base de éster de ácido carboxílico; uso de dicho compuesto para aumentar el factor de protección solar | |
| KR101408631B1 (ko) | 무스형 자외선 차단 화장료 조성물 | |
| KR20210022254A (ko) | 크로마틱 에멀젼 성상을 갖는 자외선 차단용 화장료 조성물 | |
| KR102190530B1 (ko) | 자외선 및 적외선 차단용 화장료 조성물 | |
| KR102393979B1 (ko) | 페룰산과 카프릴하이드록사믹애씨드를 포함하는 자외선 차단용 화장료 조성물 | |
| DE102019215113A1 (de) | Neues, Bismuthoxychlorid enthaltendes Sonnenschutzmittel zum Schutz vor blauem Licht | |
| KR102439913B1 (ko) | 고함량의 산화티탄을 포함하는 산화티탄 분산물 | |
| US9539195B1 (en) | Sunscreen compositions having synergistic combination of UV filters | |
| EP2630947B1 (de) | Duftstabile, wasserfeste kosmetische Zubereitung | |
| KR102830937B1 (ko) | 고함량의 징크옥사이드 분산물이 함유된 자외선 차단용 화장료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20170629 |
|
| PA0201 | Request for examination | ||
| PA0302 | Request for accelerated examination |
Patent event date: 20170704 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20170629 Patent event code: PA03021R01I Comment text: Patent Application |
|
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170727 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20171108 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20171109 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20171110 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20201027 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20211025 Start annual number: 5 End annual number: 5 |